Cresco Labs Inc.
Cresco Labs Inc. (CL.CN) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
cl.cn · stock forecast · 6 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 6 Wall Street analysts in the past 3 months
Buy
6 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $1.24
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.24 | ↓ 0.05% |
1-day model range: $1.21–$1.27. Peak: $1.27 (-0.05%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · CL.CN · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-05-16 | Needham | Maintains | Hold→Hold |
| 2024-05-16 | Wedbush | Maintains | Outperform→Outperform |
| 2024-03-14 | Roth MKM | Maintains | Neutral→Neutral |
| 2023-03-20 | Wedbush | Maintains | Outperform→Outperform |
| 2023-02-24 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2022-12-30 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2022-12-20 | Cowen & Co. | Downgrade ↓ | Outperform→Market Perform |
| 2022-08-18 | Piper Sandler | Maintains | Overweight→Overweight |
| 2022-08-18 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2022-03-24 | Piper Sandler | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Cresco Labs Inc. (CL.CN) stock. Of the recent 21 rating actions, 0 were upgrades and 1 were downgrades. 6 analysts currently cover CL.CN.
Analyst Recommendation Trends
CL.CN analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$652M
↓ 3.3% YoY
Revenue Next Year
$675M
↑ 3.6% YoY
EPS This Year
$-0.08
EPS Next Year
$-0.01
↓ 92.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast CL.CN EPS of $-0.08 for the current fiscal year, based on estimates from 1 analysts. The CL.CN revenue forecast is $652M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CL.CN stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CL.CN price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The CL.CN short-term stock prediction for tomorrow is $1.24 (-0.05%).
Cresco Labs Inc. trades on CNQ under the ticker CL.CN. The CL.CN stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.
Frequently asked questions
CL.CN forecast · 8 questionsAccording to 6 Wall Street analysts, the average 12-month CL.CN price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $1.24.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.